Clicky

Abnova Taiwan Corp(4133)

Description: Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.


Keywords: Biotechnology Biology Immunology Immune System Antibodies Antibody Glycoproteins Biochemistry In Vitro Diagnostics Hybridization Abcam Polyclonal Antibodies Assay Development Services Reagent Hybridization Products

Home Page: www.abnova.com

No. 108, Jhouzih Street
Taipei, 114
Taiwan
Phone: 886 2 8751 1888


Exchange: TW

Country: TW

Currency: New Taiwan Dollar (NT$)

Forward PE: 0
Trailing PE: 37.451
Price-to-Book MRQ: 1.9802
Price-to-Sales TTM: 5.8565
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks